Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Operations (Unaudited)

v3.23.1
Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Income Statement [Abstract]    
Revenue
Operating expenses    
Research and development 1,827,907 1,660,821
General and administrative 413,175 328,382
Total operating expenses 2,241,082 1,989,203
Loss from operations (2,241,082) (1,989,203)
Interest income 116,180 19,575
Net loss $ (2,124,902) $ (1,969,628)
Per share information:    
Net loss per common share, basic and diluted $ (0.17) $ (0.15)
Weighted average common shares outstanding, basic and diluted 12,848,165 13,063,710